Prokidney (PROK) Operating Margin (2024 - 2026)
Prokidney (PROK) reported Operating Margin of 19881.86% for Q1 2026, down 188708.0% year-over-year from N/an in Q1 2025, and down 150.9% quarter-over-quarter from 39059.56% in Q4 2025.
Prokidney (PROK) Operating Margin (2024 - 2026) Analysis & Trends
Prokidney (PROK) has 3 years of Operating Margin data on file, last reported at 19881.86% in Q1 2026.
- Operating Margin for Q1 2026 came in at 19881.86%, down 188708.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 3970.42% (up 5648318.0% YoY), and the FY2025 annual result was 3555.66%, up 23812329.0% from the prior year.
- Operating Margin retreated to 19881.86% in Q1 2026 per PROK's latest filing, from 39059.56% in the prior quarter.
- Over five years, Operating Margin peaked at 39059.56% in Q4 2025 and troughed at 67856.58% in Q4 2024.
- A 3-year average of 17066.91% and a median of 17981.33% in 2025 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2025 and 2026: Operating Margin surged 10691613 bps in 2025, then sank 188708 bps in 2026.
- A 3-year view of Operating Margin shows it stood at 67856.58% in 2024, then jumped by 158 bps to 39059.56% in 2025, then slumped by 151 bps to 19881.86% in 2026.
- Business Quant data shows PROK's Operating Margin at 19881.86% in Q1 2026, 39059.56% in Q4 2025, and 17759.91% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | -19,881.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19,881.86% |
| Dec 31, 2025 | 39,059.56% |
| Sep 30, 2025 | -17,759.91% |
| Jun 30, 2025 | -17,967.87% |
| Mar 31, 2025 | -17,994.78% |
| Dec 31, 2024 | -67,856.58% |